Laurent Fraisse
Director/Board Member at GENOWAY
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alexandre Fraichard | M | - | 25 years | |
| Craig Johnstone | M | 54 |
Evotec (France) SAS
 Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | 9 years |
| Benjamin Bruneau | M | - | 9 years | |
| Christian Grenier | M | - | - | |
| Philippe Villain-Guillot | M | - |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | 15 years |
| Maxime Gualtieri | M | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | 15 years |
| Jacques Dumas | M | 72 |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | - |
| Raffy Kazandjian | M | - | - | |
| Patrick Blain | M | 72 | - | |
| Frederic Hammel | M | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | - |
| Jean-Louis Menard | M | - | - | |
| Andre Tartar | M | - | - | |
| Olivier Antoine M. Charmeil | M | 59 | - | |
| Sandra Dubos | F | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | - |
| Martin Lauriot Prévost | M | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | - |
| Pierre Cooremans | M | 58 |
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | 5 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 16 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Laurent Fraisse
- Personal Network
